Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 273

1.

Protect the last of the wild.

Watson JEM, Venter O, Lee J, Jones KR, Robinson JG, Possingham HP, Allan JR.

Nature. 2018 Nov;563(7729):27-30. doi: 10.1038/d41586-018-07183-6. No abstract available.

PMID:
30382225
2.

Comparison of Cardiovascular Risk Factors for Coronary Heart Disease and Stroke Type in Women.

Leening MJG, Cook NR, Franco OH, Manson JE, Lakshminarayan K, LaMonte MJ, Leira EC, Robinson JG, Ridker PM, Paynter NP.

J Am Heart Assoc. 2018 Oct 2;7(19):e007514. doi: 10.1161/JAHA.117.007514.

3.

Eradicating the Burden of Atherosclerotic Cardiovascular Disease by Lowering Apolipoprotein B Lipoproteins Earlier in Life.

Robinson JG, Williams KJ, Gidding S, Borén J, Tabas I, Fisher EA, Packard C, Pencina M, Fayad ZA, Mani V, Rye KA, Nordestgaard BG, Tybjærg-Hansen A, Douglas PS, Nicholls SJ, Pagidipati N, Sniderman A.

J Am Heart Assoc. 2018 Oct 16;7(20):e009778. doi: 10.1161/JAHA.118.009778. No abstract available.

4.

Measurement of Low-Density Lipoprotein Cholesterol Levels in Primary and Secondary Prevention Patients: Insights From the PALM Registry.

Lowenstern AM, Li S, Navar AM, Roger VL, Robinson JG, Goldberg AC, Virani SS, Lee LV, Wilson PWF, Louie MJ, Peterson ED, Wang TY.

J Am Heart Assoc. 2018 Sep 18;7(18):e009251. doi: 10.1161/JAHA.118.009251.

5.

Long-Term Trends in Hypertension and Elevated Blood Pressure Among U.S. Adults, 1999 to 2016.

Liu B, Sun Y, Xu G, Rong S, Zhang J, Du Y, Snetselaar LG, Robinson JG, Wallace RB, Bao W.

J Am Coll Cardiol. 2018 Oct 23;72(17):2089-2091. doi: 10.1016/j.jacc.2018.07.086. No abstract available.

PMID:
30336835
6.

Meta-analysis of LDL-C Lowering and Mortality-Reply.

Robinson JG, Navarese EP, Andreotti F.

JAMA. 2018 Oct 9;320(14):1493-1494. doi: 10.1001/jama.2018.11198. No abstract available.

PMID:
30304424
7.

Fatty acid biomarkers of dairy fat consumption and incidence of type 2 diabetes: A pooled analysis of prospective cohort studies.

Imamura F, Fretts A, Marklund M, Ardisson Korat AV, Yang WS, Lankinen M, Qureshi W, Helmer C, Chen TA, Wong K, Bassett JK, Murphy R, Tintle N, Yu CI, Brouwer IA, Chien KL, Frazier-Wood AC, Del Gobbo LC, Djoussé L, Geleijnse JM, Giles GG, de Goede J, Gudnason V, Harris WS, Hodge A, Hu F; InterAct Consortium, Koulman A, Laakso M, Lind L, Lin HJ, McKnight B, Rajaobelina K, Risérus U, Robinson JG, Samieri C, Siscovick DS, Soedamah-Muthu SS, Sotoodehnia N, Sun Q, Tsai MY, Uusitupa M, Wagenknecht LE, Wareham NJ, Wu JH, Micha R, Forouhi NG, Lemaitre RN, Mozaffarian D; Fatty Acids and Outcomes Research Consortium (FORCE).

PLoS Med. 2018 Oct 10;15(10):e1002670. doi: 10.1371/journal.pmed.1002670. eCollection 2018 Oct.

8.

Access to PCSK9 Inhibitors.

Baum SJ, Lepor NE, Robinson JG.

Rev Cardiovasc Med. 2018;19(S1):S47-S50. No abstract available.

PMID:
30207557
9.

Can We Cure Atherosclerosis?

Robinson JG, Davidson MH.

Rev Cardiovasc Med. 2018;19(S1):S20-S24.

PMID:
30207554
10.

Identifying Patients for Nonstatin Therapy.

Robinson JG, Watson KE.

Rev Cardiovasc Med. 2018;19(S1):S1-S8.

PMID:
30207552
11.

Consistent LDL-C response with evolocumab among patient subgroups in PROFICIO: A pooled analysis of 3146 patients from phase 3 studies.

Stroes E, Robinson JG, Raal FJ, Dufour R, Sullivan D, Kassahun H, Ma Y, Wasserman SM, Koren MJ.

Clin Cardiol. 2018 Oct;41(10):1328-1335. doi: 10.1002/clc.23049. Epub 2018 Oct 21.

12.

First trimester prenatal screening biomarkers and gestational diabetes mellitus: A systematic review and meta-analysis.

Donovan BM, Nidey NL, Jasper EA, Robinson JG, Bao W, Saftlas AF, Ryckman KK.

PLoS One. 2018 Jul 26;13(7):e0201319. doi: 10.1371/journal.pone.0201319. eCollection 2018.

13.

Evaluation of the Pooled Cohort Risk Equations for Cardiovascular Risk Prediction in a Multiethnic Cohort From the Women's Health Initiative.

Mora S, Wenger NK, Cook NR, Liu J, Howard BV, Limacher MC, Liu S, Margolis KL, Martin LW, Paynter NP, Ridker PM, Robinson JG, Rossouw JE, Safford MM, Manson JE.

JAMA Intern Med. 2018 Sep 1;178(9):1231-1240. doi: 10.1001/jamainternmed.2018.2875.

PMID:
30039172
14.

Roundtable discussion: Dietary fats in prevention of atherosclerotic cardiovascular disease.

Severson T, Kris-Etherton PM, Robinson JG, Guyton JR.

J Clin Lipidol. 2018 May - Jun;12(3):574-582. doi: 10.1016/j.jacl.2018.05.006. Epub 2018 May 14. Review.

PMID:
29880281
15.

From Bottleneck to Breakthrough: Urbanization and the Future of Biodiversity Conservation.

Sanderson EW, Walston J, Robinson JG.

Bioscience. 2018 Jun 1;68(6):412-426. doi: 10.1093/biosci/biy039. Epub 2018 Apr 22.

16.

The Call for Precision Health Trials in Older Adults: One Size Does Not Fit All.

Robinson JG, Hernandez AF.

J Am Coll Cardiol. 2018 Jun 5;71(22):2537-2539. doi: 10.1016/j.jacc.2018.03.503. No abstract available.

PMID:
29852977
17.

Efficacy and Safety of Alirocumab in Individuals with Diabetes Mellitus: Pooled Analyses from Five Placebo-Controlled Phase 3 Studies.

Ginsberg HN, Farnier M, Robinson JG, Cannon CP, Sattar N, Baccara-Dinet MT, Letierce A, Bujas-Bobanovic M, Louie MJ, Colhoun HM.

Diabetes Ther. 2018 Jun;9(3):1317-1334. doi: 10.1007/s13300-018-0439-8. Epub 2018 May 19.

18.

Association Between Baseline LDL-C Level and Total and Cardiovascular Mortality After LDL-C Lowering: A Systematic Review and Meta-analysis.

Navarese EP, Robinson JG, Kowalewski M, Kolodziejczak M, Andreotti F, Bliden K, Tantry U, Kubica J, Raggi P, Gurbel PA.

JAMA. 2018 Apr 17;319(15):1566-1579. doi: 10.1001/jama.2018.2525. Review. Erratum in: JAMA. 2018 Oct 2;320(13):1387.

19.

Optimizing Statins and Ezetimibe in Guideline-Focused Management.

Bin Abdulhak AA, Robinson JG.

Cardiol Clin. 2018 May;36(2):221-223. doi: 10.1016/j.ccl.2017.12.003. Review.

PMID:
29609751
20.

Prevalence and Management of Symptoms Associated With Statin Therapy in Community Practice: Insights From the PALM (Patient and Provider Assessment of Lipid Management) Registry.

Navar AM, Peterson ED, Li S, Robinson JG, Roger VL, Goldberg AC, Virani S, Wilson PWF, Nanna MG, Lee LV, Elassal J, Wang TY.

Circ Cardiovasc Qual Outcomes. 2018 Mar;11(3):e004249. doi: 10.1161/CIRCOUTCOMES.117.004249. No abstract available.

PMID:
29545393
21.

Temporal Trends of High-Intensity Statin Therapy Among Veterans Treated With Percutaneous Coronary Intervention.

Bin Abdulhak AA, Vaughan-Sarrzin M, Kaboli P, Horwitz PA, Mosher H, Sigurdsson G, Walker NE, Wallace R, Robinson JG.

J Am Heart Assoc. 2018 Mar 4;7(5). pii: e007370. doi: 10.1161/JAHA.117.007370.

22.

The exceptional value of intact forest ecosystems.

Watson JEM, Evans T, Venter O, Williams B, Tulloch A, Stewart C, Thompson I, Ray JC, Murray K, Salazar A, McAlpine C, Potapov P, Walston J, Robinson JG, Painter M, Wilkie D, Filardi C, Laurance WF, Houghton RA, Maxwell S, Grantham H, Samper C, Wang S, Laestadius L, Runting RK, Silva-Chávez GA, Ervin J, Lindenmayer D.

Nat Ecol Evol. 2018 Apr;2(4):599-610. doi: 10.1038/s41559-018-0490-x. Epub 2018 Feb 26. Review.

23.

A Large-Scale Multi-ancestry Genome-wide Study Accounting for Smoking Behavior Identifies Multiple Significant Loci for Blood Pressure.

Sung YJ, Winkler TW, de Las Fuentes L, Bentley AR, Brown MR, Kraja AT, Schwander K, Ntalla I, Guo X, Franceschini N, Lu Y, Cheng CY, Sim X, Vojinovic D, Marten J, Musani SK, Li C, Feitosa MF, Kilpeläinen TO, Richard MA, Noordam R, Aslibekyan S, Aschard H, Bartz TM, Dorajoo R, Liu Y, Manning AK, Rankinen T, Smith AV, Tajuddin SM, Tayo BO, Warren HR, Zhao W, Zhou Y, Matoba N, Sofer T, Alver M, Amini M, Boissel M, Chai JF, Chen X, Divers J, Gandin I, Gao C, Giulianini F, Goel A, Harris SE, Hartwig FP, Horimoto ARVR, Hsu FC, Jackson AU, Kähönen M, Kasturiratne A, Kühnel B, Leander K, Lee WJ, Lin KH, 'an Luan J, McKenzie CA, Meian H, Nelson CP, Rauramaa R, Schupf N, Scott RA, Sheu WHH, Stančáková A, Takeuchi F, van der Most PJ, Varga TV, Wang H, Wang Y, Ware EB, Weiss S, Wen W, Yanek LR, Zhang W, Zhao JH, Afaq S, Alfred T, Amin N, Arking D, Aung T, Barr RG, Bielak LF, Boerwinkle E, Bottinger EP, Braund PS, Brody JA, Broeckel U, Cabrera CP, Cade B, Caizheng Y, Campbell A, Canouil M, Chakravarti A; CHARGE Neurology Working Group, Chauhan G, Christensen K, Cocca M; COGENT-Kidney Consortium, Collins FS, Connell JM, de Mutsert R, de Silva HJ, Debette S, Dörr M, Duan Q, Eaton CB, Ehret G, Evangelou E, Faul JD, Fisher VA, Forouhi NG, Franco OH, Friedlander Y, Gao H; GIANT Consortium, Gigante B, Graff M, Gu CC, Gu D, Gupta P, Hagenaars SP, Harris TB, He J, Heikkinen S, Heng CK, Hirata M, Hofman A, Howard BV, Hunt S, Irvin MR, Jia Y, Joehanes R, Justice AE, Katsuya T, Kaufman J, Kerrison ND, Khor CC, Koh WP, Koistinen HA, Komulainen P, Kooperberg C, Krieger JE, Kubo M, Kuusisto J, Langefeld CD, Langenberg C, Launer LJ, Lehne B, Lewis CE, Li Y; Lifelines Cohort Study, Lim SH, Lin S, Liu CT, Liu J, Liu J, Liu K, Liu Y, Loh M, Lohman KK, Long J, Louie T, Mägi R, Mahajan A, Meitinger T, Metspalu A, Milani L, Momozawa Y, Morris AP, Mosley TH Jr, Munson P, Murray AD, Nalls MA, Nasri U, Norris JM, North K, Ogunniyi A, Padmanabhan S, Palmas WR, Palmer ND, Pankow JS, Pedersen NL, Peters A, Peyser PA, Polasek O, Raitakari OT, Renström F, Rice TK, Ridker PM, Robino A, Robinson JG, Rose LM, Rudan I, Sabanayagam C, Salako BL, Sandow K, Schmidt CO, Schreiner PJ, Scott WR, Seshadri S, Sever P, Sitlani CM, Smith JA, Snieder H, Starr JM, Strauch K, Tang H, Taylor KD, Teo YY, Tham YC, Uitterlinden AG, Waldenberger M, Wang L, Wang YX, Wei WB, Williams C, Wilson G, Wojczynski MK, Yao J, Yuan JM, Zonderman AB, Becker DM, Boehnke M, Bowden DW, Chambers JC, Chen YI, de Faire U, Deary IJ, Esko T, Farrall M, Forrester T, Franks PW, Freedman BI, Froguel P, Gasparini P, Gieger C, Horta BL, Hung YJ, Jonas JB, Kato N, Kooner JS, Laakso M, Lehtimäki T, Liang KW, Magnusson PKE, Newman AB, Oldehinkel AJ, Pereira AC, Redline S, Rettig R, Samani NJ, Scott J, Shu XO, van der Harst P, Wagenknecht LE, Wareham NJ, Watkins H, Weir DR, Wickremasinghe AR, Wu T, Zheng W, Kamatani Y, Laurie CC, Bouchard C, Cooper RS, Evans MK, Gudnason V, Kardia SLR, Kritchevsky SB, Levy D, O'Connell JR, Psaty BM, van Dam RM, Sims M, Arnett DK, Mook-Kanamori DO, Kelly TN, Fox ER, Hayward C, Fornage M, Rotimi CN, Province MA, van Duijn CM, Tai ES, Wong TY, Loos RJF, Reiner AP, Rotter JI, Zhu X, Bierut LJ, Gauderman WJ, Caulfield MJ, Elliott P, Rice K, Munroe PB, Morrison AC, Cupples LA, Rao DC, Chasman DI.

Am J Hum Genet. 2018 Mar 1;102(3):375-400. doi: 10.1016/j.ajhg.2018.01.015. Epub 2018 Feb 15.

24.

Chart validation of inpatient ICD-9-CM administrative diagnosis codes for acute myocardial infarction (AMI) among intravenous immune globulin (IGIV) users in the Sentinel Distributed Database.

Ammann EM, Schweizer ML, Robinson JG, Eschol JO, Kafa R, Girotra S, Winiecki SK, Fuller CC, Carnahan RM, Leonard CE, Haskins C, Garcia C, Chrischilles EA.

Pharmacoepidemiol Drug Saf. 2018 Apr;27(4):398-404. doi: 10.1002/pds.4398. Epub 2018 Feb 15.

PMID:
29446185
25.

New strategies for the development of lipid-lowering therapies to reduce cardiovascular risk.

Graham I, Shear C, De Graeff P, Boulton C, Catapano AL, Stough WG, Carlsson SC, De Backer G, Emmerich J, Greenfeder S, Kim AM, Lautsch D, Nguyen T, Nissen SE, Prasad K, Ray KK, Robinson JG, Sasiela WJ, Bruins Slot K, Stroes E, Thuren T, Van der Schueren B, Velkovski-Rouyer M, Wasserman SM, Wiklund O, Zouridakis E; European Society of Cardiology Cardiovascular Roundtable.

Eur Heart J Cardiovasc Pharmacother. 2018 Apr 1;4(2):119-127. doi: 10.1093/ehjcvp/pvx031.

PMID:
29194462
26.

Lipid management in contemporary community practice: Results from the Provider Assessment of Lipid Management (PALM) Registry.

Navar AM, Wang TY, Li S, Robinson JG, Goldberg AC, Virani S, Roger VL, Wilson PWF, Elassal J, Lee LV, Peterson ED.

Am Heart J. 2017 Nov;193:84-92. doi: 10.1016/j.ahj.2017.08.005. Epub 2017 Aug 12.

27.

Incidence of and Risk Factors for Severe Adverse Events in Elderly Patients Taking Angiotensin-Converting Enzyme Inhibitors or Angiotensin II Receptor Blockers after an Acute Myocardial Infarction.

Fang G, Annis IE, Farley JF, Mahendraratnam N, Hickson RP, Stürmer T, Robinson JG.

Pharmacotherapy. 2018 Jan;38(1):29-41. doi: 10.1002/phar.2051. Epub 2017 Dec 11.

PMID:
29059475
28.

Changes in Statin Adherence Following an Acute Myocardial Infarction Among Older Adults: Patient Predictors and the Association With Follow-Up With Primary Care Providers and/or Cardiologists.

Hickson RP, Robinson JG, Annis IE, Killeya-Jones LA, Korhonen MJ, Cole AL, Fang G.

J Am Heart Assoc. 2017 Oct 19;6(10). pii: e007106. doi: 10.1161/JAHA.117.007106.

29.

Adherence Tradeoff to Multiple Preventive Therapies and All-Cause Mortality After Acute Myocardial Infarction.

Korhonen MJ, Robinson JG, Annis IE, Hickson RP, Bell JS, Hartikainen J, Fang G.

J Am Coll Cardiol. 2017 Sep 26;70(13):1543-1554. doi: 10.1016/j.jacc.2017.07.783.

30.

Cognitive Function in a Randomized Trial of Evolocumab.

Giugliano RP, Mach F, Zavitz K, Kurtz C, Im K, Kanevsky E, Schneider J, Wang H, Keech A, Pedersen TR, Sabatine MS, Sever PS, Robinson JG, Honarpour N, Wasserman SM, Ott BR; EBBINGHAUS Investigators.

N Engl J Med. 2017 Aug 17;377(7):633-643. doi: 10.1056/NEJMoa1701131.

31.

Metabolic syndrome cluster does not provide incremental prognostic information in patients with stable cardiovascular disease: A post hoc analysis of the AIM-HIGH trial.

Lyubarova R, Robinson JG, Miller M, Simmons DL, Xu P, Abramson BL, Elam MB, Brown TM, McBride R, Fleg JL, Desvigne-Nickens P, Ayenew W, Boden WE; Atherothrombosis Intervention in Metabolic Syndrome with Low HDL/High Triglycerides and Impact on Global Health Outcomes (AIM-HIGH) Investigators.

J Clin Lipidol. 2017 Sep - Oct;11(5):1201-1211. doi: 10.1016/j.jacl.2017.06.017. Epub 2017 Jul 5.

32.

Long-term treatment adherence to the proprotein convertase subtilisin/kexin type 9 inhibitor alirocumab in 6 ODYSSEY Phase III clinical studies with treatment duration of 1 to 2 years.

Farnier M, Colhoun HM, Sasiela WJ, Edelberg JM, Asset G, Robinson JG.

J Clin Lipidol. 2017 Jul - Aug;11(4):986-997. doi: 10.1016/j.jacl.2017.05.016. Epub 2017 Jun 8.

33.

Erythrocyte omega-3 fatty acids are inversely associated with incident dementia: Secondary analyses of longitudinal data from the Women's Health Initiative Memory Study (WHIMS).

Ammann EM, Pottala JV, Robinson JG, Espeland MA, Harris WS.

Prostaglandins Leukot Essent Fatty Acids. 2017 Jun;121:68-75. doi: 10.1016/j.plefa.2017.06.006. Epub 2017 Jun 15.

34.

What Women (and Clinicians) Don't Know Hurts Them.

Robinson JG.

J Am Coll Cardiol. 2017 Jul 11;70(2):133-135. doi: 10.1016/j.jacc.2017.05.037. Epub 2017 Jun 22. No abstract available.

35.

Dietary Fats and Cardiovascular Disease: A Presidential Advisory From the American Heart Association.

Sacks FM, Lichtenstein AH, Wu JHY, Appel LJ, Creager MA, Kris-Etherton PM, Miller M, Rimm EB, Rudel LL, Robinson JG, Stone NJ, Van Horn LV; American Heart Association.

Circulation. 2017 Jul 18;136(3):e1-e23. doi: 10.1161/CIR.0000000000000510. Epub 2017 Jun 15. Review. Erratum in: Circulation. 2017 Sep 5;136(10 ):e195.

PMID:
28620111
36.

Reply: Cost Effectiveness of Nonstatin-to-Statin Therapy.

Robinson JG.

J Am Coll Cardiol. 2017 Apr 18;69(15):1996. doi: 10.1016/j.jacc.2017.01.056. No abstract available.

37.

Red blood cell polyunsaturated fatty acids and mortality in the Women's Health Initiative Memory Study.

Harris WS, Luo J, Pottala JV, Espeland MA, Margolis KL, Manson JE, Wang L, Brasky TM, Robinson JG.

J Clin Lipidol. 2017 Jan - Feb;11(1):250-259.e5. doi: 10.1016/j.jacl.2016.12.013. Epub 2017 Jan 12.

38.

Clinical Trials Targeting Aging and Age-Related Multimorbidity.

Espeland MA, Crimmins EM, Grossardt BR, Crandall JP, Gelfond JA, Harris TB, Kritchevsky SB, Manson JE, Robinson JG, Rocca WA, Temprosa M, Thomas F, Wallace R, Barzilai N; Multimorbidity Clinical Trials Consortium.

J Gerontol A Biol Sci Med Sci. 2017 Mar 1;72(3):355-361. doi: 10.1093/gerona/glw220.

39.

Planning a Research Agenda to Incorporate Imaging Into Clinical Practice.

Robinson JG.

JACC Cardiovasc Imaging. 2017 Sep;10(9):1039-1041. doi: 10.1016/j.jcmg.2016.12.018. Epub 2017 Mar 15. No abstract available.

40.

Potential for Net Benefit Should Guide Preventive Therapy.

Stone NJ, Robinson JG.

Circulation. 2017 Feb 14;135(7):630-632. doi: 10.1161/CIRCULATIONAHA.116.022147. No abstract available.

PMID:
28193796
41.

Safety of Very Low Low-Density Lipoprotein Cholesterol Levels With Alirocumab: Pooled Data From Randomized Trials.

Robinson JG, Rosenson RS, Farnier M, Chaudhari U, Sasiela WJ, Merlet L, Miller K, Kastelein JJ.

J Am Coll Cardiol. 2017 Feb 7;69(5):471-482. doi: 10.1016/j.jacc.2016.11.037.

42.

Big Data Cohort Extraction to Facilitate Machine Learning to Improve Statin Treatment.

Chi CL, Wang J, Clancy TR, Robinson JG, Tonellato PJ, Adam TJ.

West J Nurs Res. 2017 Jan;39(1):42-62. doi: 10.1177/0193945916673059. Epub 2016 Oct 22.

PMID:
30208771
43.

Variation in PCSK9 and HMGCR and Risk of Cardiovascular Disease and Diabetes.

Ference BA, Robinson JG, Brook RD, Catapano AL, Chapman MJ, Neff DR, Voros S, Giugliano RP, Davey Smith G, Fazio S, Sabatine MS.

N Engl J Med. 2016 Dec 1;375(22):2144-2153.

44.

Serum lipid changes following the onset of depressive symptoms in postmenopausal women.

Persons JE, Robinson JG, Payne ME, Fiedorowicz JG.

Psychiatry Res. 2017 Jan;247:282-287. doi: 10.1016/j.psychres.2016.12.006. Epub 2016 Dec 5.

45.

Determining When to Add Nonstatin Therapy: A Quantitative Approach.

Robinson JG, Huijgen R, Ray K, Persons J, Kastelein JJ, Pencina MJ.

J Am Coll Cardiol. 2016 Dec 6;68(22):2412-2421. doi: 10.1016/j.jacc.2016.09.928. Review.

46.

The future of lipid guidelines.

Robinson JG.

Curr Opin Lipidol. 2016 Dec;27(6):585-591. Review.

PMID:
27676195
47.

Effect of Alirocumab on Lipoprotein(a) Over ≥1.5 Years (from the Phase 3 ODYSSEY Program).

Gaudet D, Watts GF, Robinson JG, Minini P, Sasiela WJ, Edelberg J, Louie MJ, Raal FJ.

Am J Cardiol. 2017 Jan 1;119(1):40-46. doi: 10.1016/j.amjcard.2016.09.010. Epub 2016 Sep 29.

48.

Safety of Alirocumab (A PCSK9 Monoclonal Antibody) from 14 Randomized Trials.

Jones PH, Bays HE, Chaudhari U, Pordy R, Lorenzato C, Miller K, Robinson JG.

Am J Cardiol. 2016 Dec 15;118(12):1805-1811. doi: 10.1016/j.amjcard.2016.08.072. Epub 2016 Sep 14.

49.

Genetic predisposition to elevated levels of C-reactive protein is associated with a decreased risk for preeclampsia.

Spracklen CN, Smith CJ, Saftlas AF, Triche EW, Bjonnes A, Keating BJ, Saxena R, Breheny PJ, Dewan AT, Robinson JG, Hoh J, Ryckman KK.

Hypertens Pregnancy. 2017 Feb;36(1):30-35. doi: 10.1080/10641955.2016.1223303. Epub 2016 Sep 22.

50.

Nonstatins and Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Inhibitors: Role in Non-Familial Hypercholesterolemia.

Robinson JG.

Prog Cardiovasc Dis. 2016 Sep - Oct;59(2):165-171. doi: 10.1016/j.pcad.2016.07.011. Epub 2016 Aug 4. Review.

PMID:
27498088

Supplemental Content

Loading ...
Support Center